v3.26.3
Business Combination - Schedule of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($)
$ in Thousands
Sep. 30, 2026
Sep. 14, 2026
Dec. 31, 2025
Business Combination [Line Items]      
Goodwill $ 855,575   $ 767,154
Convergent Genomics, Inc.      
Business Combination [Line Items]      
Cash and cash equivalents   $ 6,750  
Accounts Receivable   410  
Prepaid expenses and other current assets   347  
Property, plant and equipment, net   646  
Intangible assets, net   96,880  
Total identifiable assets acquired   105,033  
Accounts payable   146  
Accrued Liabilities   148  
Accrued employee transaction bonuses and promised option payment   2,144  
Deferred revenue   258  
Deferred tax liability   12,569  
Net identifiable assets acquired   89,768  
Goodwill   88,421  
Total purchase price   $ 178,189